EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IL-22-Activated MUC13 Impacts on Colonic Barrier Function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK Signaling

Tom Breugelmans iD, Wout Arras, Baptiste Oosterlinck iD, Aranzazu Jauregui-Amezaga, Michaël Somers, Bart Cuypers iD, Kris Laukens iD, Joris G De Man, Heiko U De Schepper, Benedicte Y De Winter iD, Annemieke Smet iD

Cells · 2023

DOI: 10.3390/cells12091224 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Tom Breugelmans und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium. Hauptthemen laut MEDLINE: Colitis, Inflammatory Bowel Diseases, Mucins. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Antwerp University Research Funds, Antwerp University Valorisation Fund, Research Foundation Flanders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Overexpression of the transmembrane mucin MUC13, as seen in inflammatory bowel diseases (IBD), could potentially impact barrier function. This study aimed to explore how inflammation-induced MUC13 disrupts epithelial barrier integrity by affecting junctional protein expression in IBD, thereby also considering the involvement of MUC1. RNA sequencing and permeability assays were performed using LS513 cells transfected with MUC1 and MUC13 siRNA and subsequently stimulated with IL-22. In vivo intestinal permeability and MUC13-related signaling pathways affecting barrier function were investigated in acute and chronic DSS-induced colitis wildtype and Muc13−/− mice. Finally, the expression of MUC13, its regulators and other barrier mediators were studied in IBD and control patients. Mucin knockdown in intestinal epithelial cells affected gene expression of several barrier mediators in the presence/absence of inflammation. IL-22-induced MUC13 expression impacted barrier function by modulating the JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK signaling pathways, with a cooperating role for MUC1. In response to DSS, MUC13 was protective during the acute phase whereas it caused more harm upon chronic colitis. The pathways accounting for the MUC13-mediated barrier dysfunction were also altered upon inflammation in IBD patients. These novel findings indicate an active role for aberrant MUC13 signaling inducing intestinal barrier dysfunction upon inflammation with MUC1 as collaborating partner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColitisInflammatory Bowel DiseasesMucinsAnimalsMiceInflammationIntestinal Mucosarho-Associated KinasesInterleukin-22Antigens, SurfaceEpidermal Growth Factor

Stichwörter der Autor:innen

inflammationintracellular signalingtight junctiontransmembrane mucin

Substanzen

Mucinsrho-Associated KinasesInterleukin-22Rock2 protein, mouseLy64 protein, mouseAntigens, SurfaceEpidermal Growth Factor

Autor:innen und Institutionen

  • Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.
  • Infla-Med Research Consortium of Excellence, University of Antwerp, 2610 Antwerp, Belgium.
  • Department of Gastroenterology and Hepatology, University Hospital of Antwerp, 2650 Antwerp, Belgium.
  • Department of Computer Science, Adrem Data Lab, University of Antwerp, 2610 Antwerp, Belgium.

ORCID-Profile: Tom Breugelmans, Baptiste Oosterlinck, Bart Cuypers, Kris Laukens, Benedicte Y De Winter, Annemieke Smet

Förderung

  • Antwerp University Research Funds
  • Antwerp University Valorisation Fund
  • Research Foundation Flanders

Zitieren

APA

Breugelmans, T., Arras, W., Oosterlinck, B., Jauregui-Amezaga, A., Somers, M., Cuypers, B., Laukens, K., De Man, J. G., De Schepper, H. U., De Winter, B. Y., & Smet, A. (2023). IL-22-Activated MUC13 Impacts on Colonic Barrier Function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK Signaling. Cells. https://doi.org/10.3390/cells12091224

Vancouver

Breugelmans T, Arras W, Oosterlinck B, Jauregui-Amezaga A, Somers M, Cuypers B, et al. IL-22-Activated MUC13 Impacts on Colonic Barrier Function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK Signaling. Cells. 2023. doi:10.3390/cells12091224

BibTeX
@article{Breugelmans2023,
  author = {Breugelmans, Tom and Arras, Wout and Oosterlinck, Baptiste and Jauregui-Amezaga, Aranzazu and Somers, Michaël and Cuypers, Bart and Laukens, Kris and De Man, Joris G and De Schepper, Heiko U and De Winter, Benedicte Y and Smet, Annemieke},
  title = {IL-22-Activated MUC13 Impacts on Colonic Barrier Function through JAK1/STAT3, SNAI1/ZEB1 and ROCK2/MAPK Signaling},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12091224}
}
Kostenlos starten →